2 To guide these conversations effectively, providers may benefit from grounding treatment recommendations in a continuum-of-care approach, one that reflects obesity as a chronic condition requiring ongoing, evolving support and acknowledges the potential out-of-pocket costs that can influence follow-through over time
Throughout this article, weve explored how these revolutionary treatments work on multiple body systems to regulate appetite, slow digestion, and control blood sugar levels
TRICARE For Life and direct care only beneficiaries lost coverage on August 31, 2025
It is stable in gastric acid and can be taken orally, which gives it a practical edge for gut applications
In May 2026, Innogen announced it will present full Phase IIb results from its ENLIGHT clinical trial at the 2026 American Diabetes Association (ADA) Scientific Sessions
Rights and permissions This article is distributed under the terms of the Creative Commons Attribution-Non-Commercial-Share Alike licence ( which permits distribution, and reproduction in any medium, provided the original author and source are credited
